BenzingaAugust 5, 2026 at 10:58 AM NY2 Months Ago
Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670
Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $650 to $670.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
